Key terms
About HRTX
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest HRTX news
Mar 21
4:42pm ET
Heron Therapeutics Announces New Principal Accounting Officer
Mar 15
11:32am ET
Biotech Alert: Searches spiking for these stocks today
Mar 13
9:41am ET
Heron Therapeutics price target raised to $5 from $4 at Needham
Mar 13
8:56am ET
Northland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX)
Mar 13
6:17am ET
Heron Therapeutics: A Strong Buy on Robust Q4 Performance and Promising Revenue Growth Prospects
Mar 12
4:11pm ET
Heron Therapeutics sees FY24 Adjusted EBITDA ($22.0M)-$3.0M
Mar 12
4:08pm ET
Heron Therapeutics reports Q4 EPS (7c), consensus (16c)
Mar 12
2:19pm ET
Heron Therapeutics options imply 11.6% move in share price post-earnings
Mar 12
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 12, 2024
Jan 26
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Jan 25
11:38am ET
Biotech Alert: Searches spiking for these stocks today
Jan 25
11:38am ET
Biotech Alert: Searches spiking for these stocks today
Jan 25
4:07am ET
Heron Therapeutics Gains FDA Nod for ZYNRELEF® Expansion
Jan 24
6:46am ET
Heron Therapeutics: Strong Buy on Zynrelef’s Market Expansion and Strategic Collaborations
Jan 23
8:07pm ET
Heron Therapeutics announces FDA approval of ZYNRELEF indication expansion
Jan 10
11:12am ET
Biotech Alert: Searches spiking for these stocks today
Jan 05
9:15am ET
Heron Therapeutics (HRTX) Gets a Buy from Northland Securities
Jan 05
9:06am ET
Heron Therapeutics named a ‘2024 Top Pick’ at Northland
No recent news articles are available for HRTX
No recent press releases are available for HRTX
HRTX Financials
Key terms
Ad Feedback
HRTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
HRTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range